Q3 2024 EPS Estimates for Aspen Aerogels, Inc. Boosted by Analyst (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at B. Riley upped their Q3 2024 earnings per share estimates for Aspen Aerogels in a research note issued on Thursday, August 15th. B. Riley analyst R. Pfingst now anticipates that the construction company will earn $0.06 per share for the quarter, up from their prior estimate of $0.03. B. Riley currently has a “Strong-Buy” rating on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.12 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.05 EPS, FY2024 earnings at $0.30 EPS, Q1 2025 earnings at $0.04 EPS, Q3 2025 earnings at $0.12 EPS, Q4 2025 earnings at $0.15 EPS and FY2025 earnings at $0.36 EPS.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. Aspen Aerogels’s revenue for the quarter was up 144.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.22) EPS.

Other analysts have also issued research reports about the company. Piper Sandler lifted their target price on Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, May 29th. Craig Hallum boosted their target price on Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, June 14th. Roth Mkm reaffirmed a “buy” rating and set a $36.00 price target (up previously from $28.00) on shares of Aspen Aerogels in a report on Wednesday, June 12th. Canaccord Genuity Group lifted their price target on shares of Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Finally, TD Cowen increased their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and an average price target of $29.70.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $30.69 on Monday. The firm has a market cap of $2.34 billion, a P/E ratio of -69.75 and a beta of 2.15. Aspen Aerogels has a twelve month low of $5.32 and a twelve month high of $33.15. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24. The company has a 50 day moving average of $24.57 and a 200 day moving average of $21.47.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 256,944 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the transaction, the chief executive officer now directly owns 502,855 shares of the company’s stock, valued at approximately $14,703,480.20. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 4.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise boosted its position in shares of Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares during the period. Point72 Hong Kong Ltd bought a new position in Aspen Aerogels in the 2nd quarter worth $84,000. nVerses Capital LLC purchased a new stake in Aspen Aerogels in the 2nd quarter worth $95,000. Point72 DIFC Ltd bought a new stake in Aspen Aerogels during the second quarter valued at about $121,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels during the second quarter valued at about $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.